These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9366028)

  • 1. Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activity.
    Azzolina O; Dal Piaz V; Collina S; Giovannoni MP; Tadini C
    Chirality; 1997; 9(7):681-5. PubMed ID: 9366028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Farmaco; 1997 Mar; 52(3):173-8. PubMed ID: 9212451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
    Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
    Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical and semi-preparative HPLC enantioseparation of novel pyridazin-3(2H)-one derivatives with α-aminophosphonate moiety using immobilized polysaccharide chiral stationary phases.
    Zhang Y; Zhang X; Zhou J; Song B; Bhadury PS; Hu D; Yang S
    J Sep Sci; 2011 Feb; 34(4):402-8. PubMed ID: 21298780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
    Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
    Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
    Jiang Q; Sun CS
    Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and absolute configuration assignment of 5-amino-1,3,5-triphenyl-pentane-1,3-diol stereoisomers.
    Uncuta C; Caraman GB; Tanase CI; Bartha E; Kravtsov VCh; Simonov YA; Lipkowski J; Vanthuyne N; Roussel C
    Chirality; 2005 Jan; 17(1):63-72. PubMed ID: 15549713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
    Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
    J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioseparation, absolute configuration determination, and anticonvulsant activity of (+/-)-1-(4-aminophenyl)-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-one.
    Calabrò ML; Raneri D; Ficarra P; Ferreri G; De Sarro G; Bruno G; Zappalà M; Micale N; Grasso S
    Chirality; 2007 Jan; 19(1):16-21. PubMed ID: 17089335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenyl-(2-pyridyl)-(3-pyridyl)-(4-pyridyl)methane: synthesis, chiroptical properties, and theoretical calculation of its absolute configuration.
    Matsumoto K; Inagaki T; Nehira T; Kannami M; Inokuchi D; Kurata H; Kawase T; Pescitelli G; Oda M
    Chem Asian J; 2007 Aug; 2(8):1031-6. PubMed ID: 17591722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
    Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
    Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect.
    Qiu YL; Hempel A; Camerman N; Camerman A; Geiser F; Ptak RG; Breitenbach JM; Kira T; Li L; Gullen E; Cheng YC; Drach JC; Zemlicka J
    J Med Chem; 1998 Dec; 41(26):5257-64. PubMed ID: 9857093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
    Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective HPLC analysis of propafenone and of its main metabolites using polysaccharide and protein-based chiral stationary phases.
    Bonato PS; de Abreu LR; de Gaitani CM; Lanchote VL; Bertucci C
    Biomed Chromatogr; 2000 Jun; 14(4):227-33. PubMed ID: 10861733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin receptor agents: synthesis, resolution by HPLC on polysaccharides chiral stationary phases, absolute configuration, and pharmacology of the enantiomers of (+/-)-N-[[2[(7-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl]acetamide.
    Lipka-Belloli E; Guelzim A; Yous S; Lefebvre J; Descamps-Francois C; Capet F; Vaccher C
    Chirality; 2001 May; 13(4):199-206. PubMed ID: 11284025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute configuration and biological activity of mequitamium iodide enantiomers.
    Di Bugno C; Dapporto P; Giorgi R; Manzini S; Paoli P; Subissi A; Arcamone F
    Chirality; 1994; 6(5):382-8. PubMed ID: 8068497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation and absolute configuration of the enantiomers of a degradation product of the new inhalation anesthetic sevoflurane.
    Schmidt R; Roeder M; Oeckler O; Simon A; Schurig V
    Chirality; 2000 Nov; 12(10):751-5. PubMed ID: 11054834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.